how does MHC class I and II differ in antigen processing prior to presentation?
I - cytosolic/endogenous (I for Inside) processing for CD8+ T cells
II - exogenous processing for CD4+ T cells
how do endogenous pathogens arise? what pathogens
pathogens mediate own entry into the cell (via endocytosis or membrane fusion) - usually viruses, some intracellular bacteria and parasite
how are endogenous peptides generated?
by proteasomes (protease complexes) (get fed intracellular proteins tagged w/ ubiquitin - polyubiquitination is proteasome degradation signal) in CYTOPLASM
(proteasomes degrade proteins into peptide fragments)
what is the 1st step of the endogenous pathway?
MHC class I alpha chain ONLY held by chaperone calnexin in ER (endoplasmic reticulum)
what is the 2nd step for the endogenous pathway?
betamicroglobulin binds to alpha chain which makes calnexin release MHC alpha chain
calreticulin+ERp57 (chaperones) makes alpha chain and beta microglobulin interact more
partly folded MHC I binds to chaperone tapasin, linked to TAP
in parallel, proteins are made in cytosol (and ubiquitinated)
what is step 3 in endogenous pathway?
polyubiquinated proteins get degraded by proteasome in cytosol (AFTER MHC I molecule partly folded)
peptide fragments brought into ER by TAP (like a tap, lets peptide fragments trickle through)
ERAAP trims peptides to fit into binding groove
trial and error (aa of peptide must fit w/ aa of binding groove)
once right peptide fits, MHC will be properly folded (all chains click into place)
what is step 4 in the endogenous pathway?
folding complete of peptide bound MHC = pMHC
release from TAP, MHC I vesicle formation, targeted for cell membrane
how do exogenous pathogens arise?
pathogen entry mediated by immune cells via phagocytosis - extracellular bacteria, parasites, fungi
how are exogenous peptides generated?
internalised antigen in endocytic vesicles (endosomes) fuses with lysosome to form phagolysosome where antigen degradation occurs
at same time as MHC II molecules produced
where is MHC-II molecule formed? pMHCII?
ER, cytosol
what is the structure of MHC-II? purpose?
has an invariant chain (Ii) (w/ CLIP (class-II associated invariant chain peptide)) which binds to peptide binding groove
li tail guides MHC-II to endocytic vesicles, once in vesicle, proteolytic activity degrades li leaving CLIP only - CLIP prevents peptides from binding too early in ER
what happens to li?
initially degraded by proteolytic activity w/in endocytic compartments
what is step 1 in the exogenous pathway?
li in complex with MHC-II in ER in Er and still in endocytic vesicle
what is step 2 in the exogenous pathway?
due to acidification of endosome, li is cleaved by proteases leaving CLIP bound to MHCII
what is step 3 in the exogenous pathway?
endosome fuses w/ vesicle containing degraded peptide - CLIP still blocking access
what is step 4 in the exogenous pathway?
HLA-DM always bound to and stabilises MHC-II after peptides in vesicle, HLA-DM releases CLIP
peptide can now bind peptide binding groove
pMHC-II targeted to cell surface
what can MHC class I molecules present other than pathogen antigens?
self-peptides
antigens of cells w/ defective proteins or near their expiration date (for turnover of proteins and cells)
what are key differences between the endogenous and exogenous pathway?
endo:
pathogen mediated entry
MHC molecule produced first and peptide generation after
exo:
phagocytosis/endocytosis
MHC molecule production and peptide generation at the same time
what does HLA-DM stand for?
Human Leukocyte antigen-DM
how many MHC molecules can be found in a vesicle?
many (more than one)
how does HLA-DM know when to remove CLIP?
pH drops in vesicle and at low pH, HLA-DM changes conformation of MHC II, releasing CLIP
CLIP also has low affinity to MHC